-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Monte Rosa Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Monte Rosa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $4.87M, a 22.6% increase year-over-year.
- Monte Rosa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.7M, a 42.9% increase from 2022.
- Monte Rosa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.7M, a 124% increase from 2021.
- Monte Rosa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.2M, a 1369% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)